AI-generated draft from CMS source. Review and verify clinical accuracy before use.
CLINICAL STAGE / CARE PATHWAY
Patient is currently in the therapeutic intervention stage of care due to persistent lumbar or sacral radicular or axial pain that has not adequately responded to conservative management, supporting progression to an interlaminar epidural steroid injection of the lumbar or sacral region.
– Sequencing logic:
Interlaminar epidural steroid injections are typically considered after trial of conservative care such as physical therapy, medication, and activity modification have failed to provide adequate symptom relief. Diagnostic selective nerve root blocks may precede therapeutic injections to localize pain generators and support medical necessity.
ICD-10 / DIAGNOSIS SUPPORT
The documented diagnosis includes lumbar or sacral radiculopathy, spinal stenosis, or degenerative disc disease consistent with interlaminar epidural steroid injection for pain management.
Clinical presentation and imaging correlate with the diagnosis and justify targeted epidural injection at the appropriate anatomic level(s).
– Example ICD-10 options:
M47.26 – Other spondylosis with radiculopathy, lumbar region
M48.062 – Spinal stenosis, lumbar region with neurogenic claudication
M54.16 – Radiculopathy, lumbar region
M51.16 – Intervertebral disc disorders with radiculopathy, lumbar region
M99.23 – Subluxation stenosis of neural canal of lumbar region
SUBJECTIVE / HPI SUPPORT
Patient reports chronic low back pain with radiation to the lower extremities, describing burning and aching quality, worsening over greater than 6 weeks despite prior conservative treatment. The pain limits sitting, standing, walking, and sleep, causing significant impairment in activities of daily living and work capacity.
– Edit if needed:
greater than 3 months
right leg pain
left leg pain
bilateral leg pain
CONSERVATIVE CARE / PRIOR TREATMENT
Patient has undergone conservative management including formal physical therapy, physician-directed home exercise program, NSAID medication trial, activity modification, and possibly prior oral neuropathic agents without sustained functional improvement.
– Common conservative care examples:
Physical therapy for minimum 4-6 weeks
NSAID therapy trial
Activity modification
Home exercise program
Prior analgesic or adjunct pharmacologic medication trials
– Documentation tip:
Include duration and response to each conservative modality.
OBJECTIVE / DIAGNOSTIC SUPPORT
Physical examination reveals lumbar spine tenderness, limited range of motion, and radicular signs consistent with nerve root irritation.
Imaging studies demonstrate degenerative changes or spinal stenosis at the targeted lumbar or sacral levels correlating with clinical symptoms.
Diagnostic selective nerve root blocks or prior epidural injections provided documented temporary pain relief supporting specific spinal level involvement.
ASSESSMENT
Assessment: Chronic lumbar radiculopathy and/or axial pain with persistent functional impairment despite comprehensive conservative care. History, clinical findings, diagnostic imaging, and prior intervention responses support medical necessity for interlaminar epidural steroid injection targeting lumbar/sacral levels.
PLAN / NEXT STEP
Plan: Proceed with image-guided interlaminar epidural steroid injection at the lumbar or sacral level(s) corresponding to the clinically diagnosed pain generator. Patient informed about risks, benefits, and alternatives. Documentation supports medical necessity given prior treatment failure and ongoing symptoms.
– Edit if needed:
right-sided lumbar
left-sided lumbar
bilateral lumbar
L4-L5 level
L5-S1 level
PROCEDURE-SPECIFIC CLINICAL REQUIREMENTS
Performed with fluoroscopic or CT imaging guidance confirming needle placement and contrast flow in the epidural space.
Documentation includes baseline pain score and estimated percent pain relief from prior diagnostic or therapeutic epidural injections if applicable.
No more than one spinal region treated per session; lumbar/sacral region only for CPT 62323.
No more than 4 epidural injection sessions per spinal region allowed in rolling 12-month period.
Use of biologicals or non-FDA approved injectants into epidural space is not supported and may result in denial.
FOLLOW-UP / RESPONSE DOCUMENTATION
Patient reports measurable improvement in pain severity, sitting and standing tolerance, walking endurance, and sleep quality following the injection.
Pain relief and functional gains are consistent with expected outcomes from interlaminar epidural steroid injection. Document duration and percentage of pain relief for continued assessment.
– Edit if needed:
greater than 50% pain relief
relief lasting several weeks to months
MISSING DOCUMENTATION CHECK
– Documentation items to confirm:
Symptom duration
Description of functional limitations
Prior conservative care details and duration
Medication trials
Physical therapy and home exercise programs
Imaging correlation
Focused physical exam findings
Baseline and post-injection pain scores
Percent and duration of pain relief from prior injections
Targeted spinal levels and laterality
ICD-10 diagnosis support
APPEAL / PEER-TO-PEER CLINICAL SUPPORT
The requested interlaminar epidural steroid injection at the lumbar/sacral level is clinically supported by the documented diagnosis, ongoing symptoms refractory to conservative care, and objective findings correlating with symptom location. The record supports medical necessity for this therapeutic intervention.
Clinical documentation confirms appropriate patient selection consistent with current standards for epidural steroid injections in the lumbar/sacral region for radicular and axial pain syndromes.
COVERED SERVICES AND PROCEDURE CODES
– Medicare covers epidural steroid injections (ESIs) for pain management per LCD L39240 and Article A58993.
– Covered CPT codes include interlaminar epidural injections (62321, 62323 with and without imaging guidance) and transforaminal epidural injections (64479, 64480, 64483, 64484) with imaging guidance (fluoroscopy or CT).
– One spinal region per date of service; only one level for 62321/62323, up to two total levels per session for 64479-64484.
– Maximum 4 epidural injection sessions per spinal region in any rolling 12-month period regardless of levels.
– Use modifier 50 for bilateral transforaminal procedures (64479-64484); caudal and interlaminar codes (62321, 62323) are not bilateral procedures.
– For diagnostic selective nerve root blocks (DSNRB), append the -KX modifier to indicate medical necessity; improper use may trigger audit.
– Epidural injection codes should not be used to bill chemotherapy or complex drug administration.
DIAGNOSTIC AND MEDICAL NECESSITY REQUIREMENTS
– Supporting documentation must demonstrate medical necessity with appropriate ICD-10 codes, clinical assessment, and relevant medical history.
– Covered ICD-10 codes generally relate to radiculopathy, spinal stenosis, postherpetic neuropathy, postlaminectomy syndrome, and other nerve root compressive disorders.
– Baseline pain score and pain relief percentage immediately post selective nerve root block must be documented.
– Imaging studies with minimum 2 views documenting needle placement and contrast flow must be retained.
– Use of epidural injections for post-operative pain management, implantable infusion pump trials, and cerebrospinal fluid flow imaging have different diagnosis code restrictions (not applicable).
– Documentation must be legible, dated, signed, and identifiable to patient.
UTILIZATION, FREQUENCY, AND BILLING GUIDANCE
– One spinal region treated per session, max two levels treated with 64479-64484, one level with 62321/62323.
– No more than 4 injection sessions per spinal region in any 12-month rolling period.
– Use one line with one unit for unilateral transforaminal codes; for bilateral, append modifier 50 on one line.
– ASC facilities report bilateral procedures on two separate lines with RT and LT modifiers; physicians use modifier 50.
– Follow National Correct Coding Initiative (NCCI) edits and outpatient prospective payment system (OPPS) packaging rules.
MODIFIERS AND CODING PRECAUTIONS
– Do not bill epidural injection codes for non-covered services; use appropriate modifiers for non-covered or denied services.
– Append -KX modifier for diagnostic selective nerve root block distinct from therapeutic injections; improper modifier usage leads to focused medical review.
– Modifier 50 required for bilateral transforaminal injections; not valid for bilateral caudal or interlaminar injections.
ANESTHESIA, BIOLOGICALS, AND NONCOVERED SERVICES
– Moderate or deep sedation, general anesthesia, and monitored anesthesia care (MAC) are generally not reimbursable and rarely medically necessary for ESIs; must document unequivocal necessity if used.
– Use of non-FDA approved injectants such as biologicals (amniotic/placenta-derived products, platelet rich plasma, vitamins) in epidural injections is not covered and may cause entire claim denial.
– Chemotherapy or complex drug administration billed with epidural injection codes is not allowed.
DENIAL RISKS AND DOCUMENTATION EXPECTATIONS
– Denials may occur for failure to meet medical necessity, improper use of modifiers, exceeding frequency limits, or usage of non-covered substances.
– Maintain comprehensive, legible, signed medical records supporting diagnosis, clinical findings, procedure indications, and imaging documentation.
– Provide documentation promptly upon contractor request for audit or review.
PROVIDER AND WORKFLOW NOTES
– Only one spinal region can be treated per date of service; coordinate billing and clinical scheduling accordingly.
– Document and bill each additional injection level separately when using codes 64480 or 64484 in conjunction with 64479 or 64483, respectively.
– Use fluoroscopy or CT imaging guidance for coded procedures requiring it; documentation of imaging is required to justify billing.
– Distinguish diagnostic nerve root blocks from therapeutic epidural injections via modifier and documentation.
– Implantable infusion pump trial injections have different diagnosis code restrictions; verify correct coding.
REFERENCES
– Refer to LCD L39240 for detailed coverage criteria.
– Follow CMS Medicare National Coverage Determinations Manual, Medicare Claims Processing Manual, and NCCI guidelines for coding edits.
– Article A58993 version 16 effective 09/11/2025 provides current billing and coding guidance.